Claes-Göran Löfdahl
91 – 100 of 147
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
Bättre rutiner krävs vid nebuliseringsterapi. Nya europeiska riktlinjer ger vägledning även för svensk vård
(
- Contribution to journal › Article
-
Mark
Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler.
(
- Contribution to journal › Article
- 2001
-
Mark
Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler
(
- Contribution to journal › Article
-
Mark
Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial
(
- Contribution to journal › Article
-
Mark
Respiratory symptoms relate to physiological changes and inflammatory markers reflecting central but not peripheral airways. A study in 60-year-old 'healthy' smokers and never-smokers
(
- Contribution to journal › Article
-
Mark
Adding formoterol to budesonide in moderate asthmatics is cost saving - Results from the FACET Study
(
- Contribution to journal › Article
-
Mark
Increased serum levels of carbohydrate-deficient transferrin in patients with chronic obstructive pulmonary disease
(
- Contribution to journal › Article
-
Mark
Adding formoterol to budesonide in moderate asthma--health economic results from the FACET study
(
- Contribution to journal › Article
-
Mark
Exudation of plasma and production of thromboxane in human bronchi after local bradykinin challenge
(
- Contribution to journal › Article
-
Mark
Neutrophil-associated activation markers in healthy smokers relates to a fall in DL(CO) and to emphysematous changes on high resolution CT
(
- Contribution to journal › Article